Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05942066Recruiting

Feasibility Study Aiming at Pre-Analytical Standardization of Whole Blood Processing for Liquid Biopsy Applications

Role: lead

NCT05054010Active Not Recruiting

Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants

Role: lead

NCT04964271Active Not Recruiting

Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants

Role: lead

NCT06097156Recruiting

Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications

Role: lead

All 4 trials loaded